Bank of New York Mellon’s NGM Biopharmaceuticals, Inc. Common Stock NGM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
|
|||||
|
2024
Q1 | $212K | Sell |
|
|||||
|
2023
Q4 | $119K | Sell |
|
|||||
|
2023
Q3 | $149K | Sell |
|
|||||
|
2023
Q2 | $361K | Buy |
|
|||||
|
2023
Q1 | $541K | Sell |
|
|||||
|
2022
Q4 | $670K | Sell |
|
|||||
|
2022
Q3 | $1.97M | Buy |
|
|||||
|
2022
Q2 | $1.68M | Sell |
|
|||||
|
2022
Q1 | $2.02M | Buy |
|
|||||
|
2021
Q4 | $2.28M | Buy |
|
|||||
|
2021
Q3 | $2.46M | Buy |
|
|||||
|
2021
Q2 | $2M | Buy |
|
|||||
|
2021
Q1 | $2.32M | Sell |
|
|||||
|
2020
Q4 | $2.52M | Sell |
|
|||||
|
2020
Q3 | $1.35M | Buy |
|
|||||
|
2020
Q2 | $1.6M | Sell |
|
|||||
|
2020
Q1 | $1.01M | Buy |
|
|||||
|
2019
Q4 | $1.08M | Buy |
|
|||||
|
2019
Q3 | $345K | Buy |
|
|||||
|
2019
Q2 | $176K | Buy |
|